Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

We recommend the following alternatives

W IP         H M R Mk Dg
REACTIVITY SENSITIVITY MW (kDa) SOURCE
205 Rabbit

Product Usage Information

Storage: Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

Afadin Antibody recognizes endogenous levels of total afadin protein. Based on sequence homology, the antibody is expected to recognize all isoforms of afadin.


Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro574 of human afadin protein. Antibodies are purified by protein A and peptide affinity chromatography.

In multicellular organisms, intercellular junctions play essential roles in tissue integrity and maintenance of cell polarity. Tight junctions (TJs) form a continuous barrier to fluids across the epithelium and endothelium (reviewed in 1). Adherens junctions (AJs) are dynamic structures that form cell-cell contacts linking cells into a continuous sheet (reviewed in 2). The actin filament-binding protein, Afadin, binds to nectin forming a connection to the actin cytoskeleton (3). AJs are formed when nectin assembles cadherin at the cell-cell adhesion site and these junctions are then involved in the formation and maintenance of TJs (4,5). Afadin has two splice variants: l-afadin, which is ubiquitously expressed, and s-afadin, which is expressed predominantly in neural tissue. s-Afadin is a shorter form lacking one of the three proline-rich regions found in l-afadin, as well as the carboxyl-terminal F-actin binding region (6). Human s-afadin is identical to AF-6, the ALL-1 fusion partner involved in acute myeloid leukemias (7). Recent work has also shown that afadin is involved in controlling the directionality of cell movement when it is localized at the leading edge of moving cells (8,9).


1.  Harris, T.J. and Tepass, U. (2010) Nat Rev Mol Cell Biol 11, 502-14.

2.  Ikeda, W. et al. (1999) J Cell Biol 146, 1117-32.

3.  Sato, T. et al. (2006) J Biol Chem 281, 5288-99.

4.  Ooshio, T. et al. (2007) J Cell Sci 120, 2352-65.

5.  Mandai, K. et al. (1997) J Cell Biol 139, 517-28.

6.  Shin, K. et al. (2006) Annu Rev Cell Dev Biol 22, 207-35.

7.  Prasad, R. et al. (1993) Cancer Res 53, 5624-8.

8.  Miyata, M. et al. (2009) J Cell Sci 122, 4319-29.

9.  Miyata, M. et al. (2009) J Biol Chem 284, 24595-609.


Entrez-Gene Id 4301
Swiss-Prot Acc. P55196


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

6492
Afadin Antibody